SGS

Activities: Manufacturing Drug Delivery Research & Development Analysis

Trending Articles

  1. NICE approves KEYTRUDA as first perioperative immunotherapy for locally advanced head and neck cancer MSD's KEYTRUDA (pembrolizumab) has received NICE approval as a neoadjuvant and adjuvant therapy for resectable LA HNSCC—the first immunotherapy recommended in this...
  2. Roche launches global Phase III Elevidys trial to support EU approval for Duchenne gene therapy Roche has initiated a new Phase III study of Elevidys, aiming to generate placebo-controlled data for European Medicines Agency resubmission and expand access to the Duchenne...
  3. OpenAI launches GPT-Rosalind to accelerate life sciences research and drug discovery workflows The new AI model designed for biochemistry, genomics and pharmaceutical R&D aims to speed early-stage discovery while maintaining security and governance in regulated environments
  4. Conjugation chemistry key to unlocking next-generation oligonucleotide therapies, says Bachem As demand for oligonucleotide therapeutics accelerates, Bachem's Director of Oligonucleotide Production explains how conjugation chemistry is helping CDMOs overcome delivery...
  5. Lupin completes acquisition of VISUfarma from GHO to expand ophthalmology portfolio The addition enhances Lupin's presence in Europe and includes a portfolio of more than 60 innovative eye health products, backed by a well-established commercial infrastructure

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

Related Content

Manufacturing

Naobios and SGS partner to manufacture RSV challenge agent for vaccine trials

Naobios and SGS have partnered to produce a cGMP respiratory syncytial virus challenge agent for Controlled Human Infection Model studies, supporting faster development of vaccines against Respiratory Syncytial Virus
Regulatory

SGS granted approval for resumption of human ADME using carbon-14

The approval allows SGS to resume carbon-14 human ADME studies at its clinical pharmacology unit in Antwerp, reinstating a specialised capability in early-phase clinical research across Europe
Research & Development

SGS partners with theblood to advance menstrual blood-based diagnostics for women’s health

Collaboration aims to establish scientific and regulatory foundations for non-invasive diagnostics targeting conditions such as endometriosis and PCOS
Pharmaceutical

SGS achieves breakthrough in infectious disease research with launch of novel RSV A-strain

Derived from a 2015 circulating strain, SGS's novel RSV-A challenge agent offers a closer match to circulating RSV viruses than strains currently used in clinical research
Marketing

SGS to showcase expertise and integrated drug development services at CPhI Frankfurt 2025

This flagship event gathers pharmaceutical professionals worldwide to explore the latest trends and innovations in drug development, manufacturing and supply chain management
Research & Development

Hamilton Health Sciences chosen for BirchBioMed burn scar treatment trial

BirchBioMed announces Hamilton Health Sciences’ (HHS) Centre for Burn Research in Ontario as the first contracted clinical trial site for its Phase II/III randomised study of the naturally based compound: FS2.
Analysis

Servomex trial demonstrates greater measurement accuracy for nitrogen generator manufacturer

Servomex, a provider of gas analysis, and its trusted partner, SGS GAS, have helped Peak Scientific to achieve very low and accurate oxygen measurements with the SERVOPRO MonoExact DF310E
Subscribe now